Novartis AG Common Stock (NVS)

Depreciation & Amortization

$5.34B

TTM · Period ending: · USD

NVS logo

NVS Depreciation & Amortization

Latest reported$5.34B
NVS TTM Depreciation & Amortization ($1.28B → $5.34B)
High-resolution chart · PNG

NVS depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
5,343,822,507
5,399,000,000
5,325,000,000
5,402,000,000
6,003,000,000
5,909,000,000
6,069,000,000
6,029,000,000
7,175,000,000
7,721,000,000
8,277,000,000
8,637,000,000
7,441,000,000
7,535,000,000
7,070,000,000
6,641,000,000
6,179,000,000
5,821,000,000
6,113,000,000
6,211,000,000
6,492,000,000
6,751,000,000
6,464,000,000
6,784,000,000
6,452,000,000
5,795,000,000
5,826,000,000
5,848,000,000
5,811,000,000
5,970,000,000
5,534,000,000
5,043,000,000
5,156,000,000
5,305,000,000
6,076,000,000
6,440,000,000
6,470,000,000
6,582,000,000
6,175,000,000
5,668,000,000
5,515,000,000
5,558,000,000
5,471,000,000
5,368,000,000
5,180,000,000
4,846,000,000
4,682,000,000
4,719,000,000
4,649,000,000
4,592,000,000
4,668,000,000
4,759,000,000
4,894,000,000
4,970,000,000
4,920,000,000
5,342,000,000
5,538,000,000
5,727,000,000
5,788,000,000
4,772,000,000
4,581,000,000
3,863,000,000
3,419,000,000
3,252,000,000
2,629,000,000
2,514,000,000
2,301,000,000
2,263,000,000
2,510,000,000
2,584,000,000
2,670,000,000
2,904,000,000
2,996,000,000
2,952,000,000
2,858,000,000
2,589,000,000
2,199,000,000
2,027,000,000
1,915,000,000
2,039,000,000
1,974,000,000
1,860,000,000
1,717,000,000
1,388,000,000
1,220,000,000
1,242,000,000
1,266,000,000
1,284,000,000
1,315,000,000
1,288,000,000
1,283,000,000
870,000,000
753,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.